butorphanol has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aprea, F; Corletto, F; Ferrandis, I; Jakovljevic, S | 1 |
| Barbhaiya, RH; Garnett, WR; Morgenthien, EA; Shyu, WC; Vachharajani, NN | 1 |
1 trial(s) available for butorphanol and Liver Diseases
| Article | Year |
|---|---|
Effect of two sedative protocols and hepatosplenic disease on Doppler indices of splenic arteries in dogs: a preliminary study.
Topics: Acepromazine; Analgesics, Opioid; Animals; Arteries; Butorphanol; Dexmedetomidine; Dog Diseases; Dogs; Dopamine Antagonists; Hypnotics and Sedatives; Liver Diseases; Spleen; Splenic Diseases; Ultrasonography, Doppler | 2013 |
1 other study(ies) available for butorphanol and Liver Diseases
| Article | Year |
|---|---|
The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Area Under Curve; Biological Availability; Butorphanol; Coloring Agents; Female; Humans; Indocyanine Green; Injections, Intravenous; Liver Circulation; Liver Diseases; Male; Middle Aged; Reference Values | 1996 |